Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2026
Rhea-AI Summary
Dentsply Sirona (Nasdaq: XRAY) will present at the Leerink Partners Global Healthcare Conference on March 10, 2026 at 10:00 a.m. EST.
Investors can listen via a live audio webcast and access a replay through the Investors section of the company's website at https://investor.dentsplysirona.com.
Positive
- None.
Negative
- None.
News Market Reaction – XRAY
In the Mar 4 session, XRAY gained 1.05%, reflecting a mild positive market reaction. Our momentum scanner triggered 4 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Earnings and outlook | Positive | +15.5% | Q4/FY 2025 results, restructuring plan, and 2026 sales/EPS guidance. |
| Feb 24 | Board refresh | Positive | -2.6% | Appointment of two new directors to support Return-to-Growth plan. |
| Feb 24 | Distribution expansion | Positive | +4.7% | Expanded Burkhart partnership to include full dental technology portfolio. |
| Feb 05 | Earnings call notice | Neutral | +9.8% | Announcement of Q4/FY 2025 conference call and webcast logistics. |
| Jan 26 | Product launch | Positive | -0.1% | Launch of Surity female external catheter in U.S. continence-care market. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history shows strong positive reactions to major earnings and partnership updates, but mixed or contrary moves around governance, product news, and informational announcements.
Over the last few months, Dentsply Sirona has reported Q4 2025 results with $961M in sales and a restructuring targeting about $120M in annualized savings, alongside FY 2026 guidance. Board refreshment added two financially experienced directors to support its Return-to-Growth plan, and an expanded partnership with Burkhart broadened distribution of dental technology equipment. Product launches in continence care and prior conference-call scheduling show steady operational and communication activity. Today’s Leerink conference appearance fits into this pattern of ongoing investor outreach rather than a discrete financial catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CHARLOTTE, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 10, 2026, at 10:00 a.m. EST.
Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona is headquartered in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
InvestorRelations@dentsplysirona.com
